Hyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common complications, and optimal injection techniques. Imaging tools such as MRI can prove to be beneficial for patient assessment.
Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Procedure can reduce scleral biomechanical stiffness and rejuvenate dynamic range of focus.
The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.
TAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.
Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
A panelist discusses how different phacoemulsification technologies, including vacuum-based and fluid-based systems like the Quatera 700, impact surgical efficiency and chamber stability during cataract procedures, emphasizing the importance of optimized fluidics settings for safe outcomes.
From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.
Language can drive understanding, trust, and better outcomes for patients
During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.
In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
CAM’s regenerative healing means long-term relief and fewer visits to clinic.
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Investigators continue to break new ground, giving hope to patients, physicians.
Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.
The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3.
Need to eliminate errors results in optimization of training of novice surgeons.
Keratopigmentation technique offers therapeutic and cosmetic applications.
Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.
Shameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.
According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.
In a blog, Mackenzie Andrews, the CCO and a co-founder of Nanodropper, discusses the need to update policies on single-use and early disposal of eyedrops.
A Q&A with PPP Committee Cornea/External Disease Panel member Daniel S. Choi, MD.
Three approaches to examination provide a comprehensive overview